Association between systemic immune-inflammation index and mortality in patients receiving maintenance hemodialysis: a retrospective cohort study
- 1Department of Nephrology, Zhongshan Hospital, Fudan University, No 180 Fenglin Rd, Shanghai, China
- 2Shanghai Clinical Research Center for Kidney Disease, No 180 Fenglin Rd, Shanghai, China
- 3Shanghai Institute of Kidney and Dialysis, No 180 Fenglin Rd, Shanghai, China
Abstract
Background: Chronic inflammation is common in patients receiving maintenance hemodialysis (MHD) and is closely related to adverse clinical outcomes. The clinical significance of the systemic immune-inflammation index (SII), a composite marker derived from routine blood cell counts, has not been fully characterized in dialysis populations.
Methods: This retrospective cohort study included 408 MHD patients with a median follow-up of 33 months. SII was calculated from baseline platelet, neutrophil, and lymphocyte counts. Associations between SII and all-cause and cardiovascular mortality were evaluated using multivariable Cox proportional hazards models. Restricted cubic spline analyses were performed to assess dose–response relationships. Kaplan–Meier analyses and subgroup analyses were conducted to explore the consistency of associations.
Results: During follow-up, 91 patients died, including 39 cardiovascular deaths. Higher SII levels were associated with increased risks of both all-cause mortality (HR 1.89, 95% CI 1.29–2.77) and cardiovascular mortality (HR 2.08, 95% CI 1.21–3.57). Patients in the highest SII tertile had approximately two-fold higher risk of all-cause mortality compared with those in the lowest tertile. Kaplan–Meier analyses demonstrated significantly lower survival probabilities among patients with higher SII levels. Subgroup analyses showed generally consistent associations across most clinically relevant strata.
Conclusions: Higher SII levels were associated with increased risks of all-cause and cardiovascular mortality in patients receiving maintenance hemodialysis. These findings suggest that SII, derived from routine blood cell counts, may reflect inflammatory processes linked to adverse outcomes in dialysis populations.
Clinical trial number: Not applicable.
Supplementary information: The online version contains supplementary material available at https://doi.org/10.1186/s12882-026-05274-5.
Related
- Longitudinal trajectory characteristics of the erythropoietin resistance index and their association with all-cause mortality in maintenance hemodialysis patients
- Systemic inflammatory response index as an independent predictor of all-cause mortality in patients receiving maintenance hemodialysis: a retrospective cohort study
- Association of Maintenance Hemodialysis with Transfer to Post-Acute Rehabilitation After Stroke: A Single-Center Retrospective Cohort Study.
- Blood pressure variability and serum sodium for long-term mortality risk stratification in maintenance hemodialysis patients: a real-world retrospective cohort study
- ApoB/ApoA-I ratio and all-cause mortality in maintenance hemodialysis: a cohort study.
BibTeX
@article{wang2026association,
title = {{Association between systemic immune-inflammation index and mortality in patients receiving maintenance hemodialysis: a retrospective cohort study}},
author = {Yaqiong Wang and Jinbo Yu and Fangfang Xiang and Xuesen Cao and Bo Shen and Xiaohong Chen and Jianzhou Zou and Yi Fang and Xiaoqiang Ding and Wuhua Jiang},
journal = {BMC Nephrology},
year = {2026},
month = aug,
doi = {10.1186/s12882-026-05274-5},
url = {https://doi.org/10.1186/s12882-026-05274-5},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Association between systemic immune-inflammation index and mortality in patients receiving maintenance hemodialysis: a retrospective cohort study
AU - Yaqiong Wang
AU - Jinbo Yu
AU - Fangfang Xiang
AU - Xuesen Cao
AU - Bo Shen
AU - Xiaohong Chen
AU - Jianzhou Zou
AU - Yi Fang
AU - Xiaoqiang Ding
AU - Wuhua Jiang
PY - 2026
DA - 2026/08/12
JO - BMC Nephrology
DO - 10.1186/s12882-026-05274-5
UR - https://doi.org/10.1186/s12882-026-05274-5
AB - Background: Chronic inflammation is common in patients receiving maintenance hemodialysis (MHD) and is closely related to adverse clinical outcomes. The clinical significance of the systemic immune-inflammation index (SII), a composite marker derived from routine blood cell counts, has not been fully characterized in dialysis populations. Methods: This retrospective cohort study included 408 MHD patients with a median follow-up of 33 months. SII was calculated from baseline platelet, neutrophil, and lymphocyte counts. Associations between SII and all-cause and cardiovascular mortality were evaluated using multivariable Cox proportional hazards models. Restricted cubic spline analyses were performed to assess dose–response relationships. Kaplan–Meier analyses and subgroup analyses were conducted to explore the consistency of associations. Results: During follow-up, 91 patients died, including 39 cardiovascular deaths. Higher SII levels were associated with increased risks of both all-cause mortality (HR 1.89, 95% CI 1.29–2.77) and cardiovascular mortality (HR 2.08, 95% CI 1.21–3.57). Patients in the highest SII tertile had approximately two-fold higher risk of all-cause mortality compared with those in the lowest tertile. Kaplan–Meier analyses demonstrated significantly lower survival probabilities among patients with higher SII levels. Subgroup analyses showed generally consistent associations across most clinically relevant strata. Conclusions: Higher SII levels were associated with increased risks of all-cause and cardiovascular mortality in patients receiving maintenance hemodialysis. These findings suggest that SII, derived from routine blood cell counts, may reflect inflammatory processes linked to adverse outcomes in dialysis populations. Clinical trial number: Not applicable. Supplementary information: The online version contains supplementary material available at https://doi.org/10.1186/s12882-026-05274-5.
SN - 1471-2369
ER -